Irbesartan Tablet
Product Images NDC 83008-084

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 83008-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (150mg Label)

Image Description (150mg Label)
This text provides information about Irbesartan Tablets USP 150 mg, including details such as GTIN, NDC number, quantity, lot number, expiration date, manufacturing details, and storage instructions. It is distributed by ZM&W and offers a contact number for inquiries. Remember to store the tablets at 68 to 77 degrees F and keep them out of reach of children.*
FDA Label Image

Image Description (75mg Label)

Image Description (75mg Label)
This is a description for Irbesartan Tablets USP 75 mg packaged and distributed by Zmz; ém Products. The tablets are prescribed and manufactured for Camber Pharmaceuticals, Inc. in Piscataway, NJ, with manufacturing conducted by Hetero Labs Limited in India. The tablets should be stored at 68 to 77 degrees F and each tablet contains 75 mg of Irbesartan USP. The product comes in a pack of 30 tablets with a GTIN of 00383008085300 and NDC: 83008-085-30. The expiration date and lot number are not provided in the text. For any inquiries, contact 1-800-337-8603.*
FDA Label Image

Image2 (Camber1)

Image2 (Camber1)
FDA Label Image

Image1 (Image1)

Image1 (Image1)
FDA Label Image

Image2 (Image2)

Image2 (Image2)
FDA Label Image

Irbesartan-figure-3 (Irbesartan Figure 3)

Irbesartan-figure-3 (Irbesartan Figure 3)
This text indicates a chart displaying the Cumulative Event Rate in percentages over several months of Follow-up for different treatments including Losartan, Irbesartan, Amlodipine, and Placebo. The data shows the number of events occurring over time for each treatment.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.